Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 10023944

Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
1999 Jan 2
First author
Source null

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 1999 Jan 2;353(9146):6-7. doi: 10.1016/S0140-6736(05)74876-5.
    note
    Source null
    related pmid
    10023941
    relationship
    Comment in

Authors and identifiers

    Complete bibliographic record and source provenance
    authors
      bibliography ids
      1. nci-bib-e6789f6bed7fb6708e54c85e
      book metadata
      content sha256
      42f1aac77b5fc5a3e6ed0da571920be65216426057e757731ffedce3f703d377
      document type
      citation
      dois
        electronic publication date
        display
        Source null
        precision
        missing
        year
        Source null
        evidence scope
        bibliographic_metadata_only
        id
        pubmed:10023944
        immutable id
        pubmed:10023944@42f1aac77b5fc5a3e6ed0da571920be65216426057e757731ffedce3f703d377
        journal
        abbreviation
        Lancet
        issn electronic
        Source null
        issn print
        0140-6736
        issue
        9146
        name
        Lancet (London, England)
        nlm unique id
        2985213R
        pages
        14-7
        volume
        353
        languages
        1. eng
        notices
        absence is not clearance
        true
        has correction metadata
        false
        has expression of concern metadata
        false
        has retraction in link
        false
        pubmed marks article retracted
        false
        pubmed marks retraction notice
        false
        relationships
        1. citation
          Lancet. 1999 Jan 2;353(9146):6-7. doi: 10.1016/S0140-6736(05)74876-5.
          note
          Source null
          related pmid
          10023941
          relationship
          Comment in
        outcomes validated
        false
        pmid
        10023944
        provenance
        batch id
        7e001e36165c25a91a06
        provider
        NCBI PubMed ESummary
        record sha256
        07c8281f80c6b352c6ff35c25bb37f13b6f407bcf63458e133de6616390c9772
        response sha256
        3515b9c50c264ae766881ea5a6c5cb10e3af8e45341fd57a5bedfa1946d08222
        retrieved at
        2026-09-09T23:45:31.509029+00:00
        publication date
        display
        1999 Jan 2
        precision
        day
        year
        1999
        publication types
        1. Clinical Trial
        2. Comparative Study
        3. Journal Article
        4. Multicenter Study
        5. Randomized Controlled Trial
        6. Research Support, Non-U.S. Gov't
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/10023944/
        title
        Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators.

        Preserved source evidence · Not medical advice